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Abstract Ex vivo rat brain microvessels express receptors for
native as well as for oxidized low-density lipoproteins. In brain
microvessels-derived endothelial cells, the expression levels of
both receptors were enhanced by co-cultivation with rat astro-
cytes, even in the absence of actual contact between the two cell
types, suggesting a soluble factor(s)-based mechanism of induc-
tion. No modulation e¡ect could be evidenced in a heterologous
cellular system. Since both receptors were found to be expressed
also in astrocytes, these cells are likely to contribute substan-
tially to the lipoprotein management at the blood^brain barrier
and in the brain compartment. % 2002 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
The importance of the superfamily of low-density lipopro-
tein (LDL) receptors [1^4] in the cerebral compartment has
been emphasized by the evidence, in several neurodegenerative
disorders, of an altered lipoprotein(s) metabolism [5^7].
Although most investigations have focused on the metabolic
pathways within the brain compartment, the endothelial lining
of brain microvessels, which is the anatomic and functional
equivalent of the blood^brain barrier (BBB) and thus regu-
lates the uptake of nutrients and of speci¢c macromolecules
from the general circulation [8,9], is likely to be somehow
involved in such metabolic derangement(s).
A speci¢c receptor for native LDL (LDL-R) has been
shown, both at the protein [10] and at the mRNA levels
[11], to occur in brain endothelial cells. As in other tissues,
LDL-R is unable to bind modi¢ed lipoproteins, for which
there are instead, in several cell types including brain micro-
vessels, appropriate ‘scavenger receptors’ [3,11^13]. A third
class of receptors for moderately oxidized LDL, namely
LOX1-R, has been identi¢ed and cloned in the last few years
[4,14]. Little is however known about its cellular distribution
in the di¡erent tissues and, in particular, in brain. The endo-
thelium of brain microvessels is reportedly somewhat di¡er-
ent, on the other hand, from other endothelia [8], presumably
as a consequence of its interaction with adjacent cells, in pri-
mis astrocytes [9,15]. In vitro, most of its peculiarities can
indeed be induced (or their loss can be prevented) by co-cul-
turing brain endothelial cells together with astrocytes [16]. In
such co-cultures, an up-regulation of LDL-R has been docu-
mented [17,18], whereas no data about LOX1-R modulation
have been published.
The aim of this work was to study the expression pattern of
both LDL-R and LOX1-R in brain microvessels endothelial
cells and its modulation by astrocytes.
2. Materials and methods
2.1. Chemicals
Random hexamers and oligo-d(T)16 were obtained from Boehringer
Mannheim GmbH (Mannheim, Germany). M-MuLV reverse tran-
scriptase (cloned), Super Taq (Thermus thermophilus DNA polymer-
ase), human placental ribonuclease inhibitor, bu¡er for reverse tran-
scription, bu¡er for PCR and xX/HaeIII marker were obtained from
HT Biotechnology Ltd. (Cambridge, England). Oligonucleotides used
as primers were synthesized by M-Medical Genenco (Florence, Italy).
All other chemicals were obtained from Sigma Chemical Co. (St.
Louis, MO, USA).
2.2. Isolation of brain microvessels and cell culture
Rat brain microvessels (RBM) were isolated from rat (Rattus nor-
vegicus) brain cortex, as previously described [19]. Primary in vitro
cultured endothelial cells from RBM (RBM-EC) were obtained from
capillary fragments and cultured as previously reported [19]. At the
10^12th day, the cells exhibited typical endothelial features and were
positive for von Willebrand factor. Aorta was used as source of in
vitro cultured bovine aorta endothelial cells (BAEC) as described [20].
Primary cultures of rat (Rattus norvegicus) astrocytes (RA) were ob-
tained from corpus callosum of 5 day old rats, as described [21]. The
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¢nal RA cell population exhibited full immunoreactivity toward glial
¢brillary acidic protein. Co-cultures of RA and RBM-EC were per-
formed in multiwell plates, using tissue culture inserts with 3.0 Wm
diameter membrane pores, under two di¡erent sets of conditions. In
the former system, named ‘without contact’, RA were plated on the
bottom of the multiwells plate; when they had grown to con£uency,
RBM-EC were then seeded (25^30 000/cm2) on the upper side of the
precoated insert membrane and cultured, up to con£uence, for
8^10 days. In the alternative ‘with contact’ system, instead, the RA
were plated on the underside of the insert membrane, whose upper
side was then seeded, as in the other system, with RBM-ECs.
We de¢ned the above described RA and RBM-EC co-cultures as
homologous and the co-cultures of RA and BAEC as heterologous;
the heterologous co-cultures were performed as above described for
homologous. All cell cultures were collected by trypsinization and
usually stored at 380‡C before RNA extraction.
2.3. RNA extraction and cDNA synthesis
Total RNA extraction from microvessels or from cells was per-
formed by the acid guanidinium/thiocyanate/phenol-chloroform pro-
cedure [22]. Reverse transcription was performed with 1 Wg of total
RNA by using, in each sample, either 150 pmol of random hexamers
or 50 pmol of oligo-d(T)16 (preferred for semiquantitative assays),
with 80 U per sample of M-MuLV reverse transcriptase at 42‡C for
1 h, in the manufacturer’s assay bu¡er (20 Wl ¢nal volume) plus 20 U
of human placental ribonuclease inhibitor per sample and 300 WM
dNTPs, followed by heat inactivation at 94‡C for 5 min. In subse-
quent ampli¢cation reactions, 2^5 Wl of these RT samples were used
for each PCR panel. Using control samples without reverse transcrip-
tase treatment, any genomic DNA contamination was excluded (data
not shown).
2.4. PCR strategy and semiquantitative assay
In Table 1 are summarized the primers used for ampli¢cation. In all
reactions 10 pmol of each primer and 0.5 U of Super Taq DNA
polymerase were used. PCR was performed in a ¢nal volume of
25 Wl in the manufacturer’s assay bu¡er plus 175 WM dNTPs. For
semiquantitative assays we performed a scalar number of cycles on a
¢xed quantity of cDNA [23], the results being then normalized by the
independent ampli¢cation of L- or Q-actin, used as control genes; the
coe⁄cient of variation between actin signals relative to di¡erent ex-
perimental conditions was, in the linearity range of the assay, less than
10%. After an initial denaturation step of 3 min at 94‡C, we per-
formed, on a Perkin Elmer Cetus Thermal Cycler mod. 480 for
each sample panel, 23, 26, 29, 32 and 35 cycles (to assess the linearity
range of the assay) of 1 min at 94‡C, 1 min at 62‡C, 1.5 min at 72‡C,
with a ¢nal 7 min step at 72‡C. Electrophoresis of 15 Wl of the PCR
reaction (out of 25 Wl) was performed under standard conditions. All
gels were photographed with a POLAROID camera DS-34 using
POLAROID b/w 667 ¢lms. The quanti¢cation was performed with
a CCD imaging system [24], using a KODAK Megaplus (mod. 1.4)
camera for scanning of the ¢lms, and a BIO IMAGE (Genomic So-
lutions) computerized densitometer for image acquisition. The ratio of
the densitometry of speci¢c receptor signal with that of corresponding
actin signal and the average ratio of at least three values falling in the
linearity range of the assay were calculated. The results were expressed
as the percentage of highest mean signal ratio (set to 100%).
3. Results
The expression of LDL-R (Fig. 1A) and of LOX1-R (Fig.
1B) was evidenced in RBM (lane 3), RBM-EC (lane 4) and
RA (lane 5). These experiments had not been planned for a
semiquantitative approach, and the di¡erences in the signal
intensities should therefore not be taken into account; in par-
ticular the high intensity of LDL-R signal in RBM-EC (Fig.
1A, lane 4) depends on the high number of cycles performed,
being a correct densitometric evaluation performed by scalar
number of cycles reported in Fig. 2 (19% of maximal signal).
In Fig. 2 are reported the expression levels of LDL-R and of
LOX1-R in RA and RBM, as well as RBM-EC cultured alone
or in contact with RA. Both receptors were expressed at high-
er levels in RA (lanes 7) than in RBM (lanes 8). In the RBM-
EC there was a further decrease, more marked for LDL-R
than for LOX1-R, in the expression of both receptors (lanes
9). The apparent absence of LDL-R signal in RBM-EC (Fig.
2A, lane 9) depends on the low number of cycles performed in
the panel shown in the ¢gure, being a correct densitometric
evaluation (reported as % of maximal signal in the ¢gure)
performed also by a higher number of cycles. Co-culture
with RA produced, in RBM-EC, a considerable enhancement
Table 1
Primers used for the ampli¢cation
Receptor s Primer sequence amp dim
LDL-R [34] f 5P-TGCACTCCATCTCCAGCATCG-3P B+R 392 bp
b 5P-GAGGCAGCTTCTCATGTCCTTGG-3P
LOX1-R [35] f 5P-GCAAACTCTTCAGGTCCTTGTCC-3P R 742 bp
b 5P-GGAAATTGAGCAGAAAGCATCC-3P
L-actin [36] f 5P-ACCCAGGCATCGCTGACAGGATGC-3P R 216 bp
b 5P-CCGCCTAGAAGCATTTGCGGTGCACG-3P
LOX1-R [37] f 5P-AATCCAAGAAACTAATGGAACTTCACCGCC-3P B 597 bp
b 5P-TCAACCAGTAGCAGGCATTTCCCTGG-3P
Q-actin [38] f 5P-TTCCAGCAGATGTGGATCAG-3P B 342 bp
b 5P-AGCCGCATATAACTAGGGGT-3P
The kind of receptor, strand speci¢city (‘s’, with f = forward; b=backward), primer sequence, use in ampli¢cation (‘amp’) of bovine (B) or rat
(R) sequences, and dimension (‘dim’) of ampli¢ed products are indicated.
Fig. 1. Both LDL-R (A) and LOX1-R (B) are expressed in RBM,
RBM-EC and in RA. Lane 2=negative control; lanes 1 and
6=xX/HaeIII marker. These ampli¢cations cannot be assumed to
re£ect quantitative di¡erences.
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of the expression of both receptors (lane 10). This e¡ect,
though depending on the presence of astrocytes, did not re-
quire a physical contact between the two kinds of cells : as
shown in Fig. 3, the signal intensities of both LDL-R (lanes
6^8) and LOX1-R (lanes 10^12) were higher in the presence of
RA than in their absence, independently from RBM-EC/RA
contact. These results were con¢rmed by a semiquantitative
densitometric analysis, reported in Figs. 2 and 3 as receptor/L-
actin densitometric ratio (%). The normalization of receptor
signal densitometry by actin signal densitometry, by the scalar
number of cycles approach, removed minor variations be-
tween actin expression in di¡erent samples, more evident in
some panels (those performed at lower number of PCR cycles,
one of which showed in Fig. 2A) but less evident in other
panels (those performed at higher number of PCR cycles,
one of which showed in Fig. 2B). The enhancement of expres-
sion of both receptors by RA was not observed in a heterol-
ogous system of co-cultures of BAEC/RA (Fig. 4): the signals
of both LDL-R (lanes 5 and 6) and LOX1-R (lanes 8 and 9)
in BAEC were similar, independently from RA presence either
without BAEC/RA contact (Fig. 4) than with contact (data
not shown).
4. Discussion
In brain microvessels there is a consistent expression of
LDL-R, both as protein [10] and as mRNA (our results).
As suggested by Dehouck and co-workers [18], astrocytes
are likely to be responsible for this peculiar expression of
LDL-R in the cerebrovascular district. On the other hand
the expression of this receptor is markedly down-regulated
in other vascular districts [25], as for example in aorta endo-
thelium, presumably due to the combined e¡ects of the high
cellular density and of the continuous exposure to circulating
serum lipoproteins. In this work we found that the expression
pattern of LOX1-R was quite similar to that of LDL-R: a
decreased expression when shifting from RBM to RBM-EC
(Fig. 2) with this e¡ect not only prevented but even over-
corrected, presumably by an induction mechanism, if RBM-
EC were co-cultured with RA (Figs. 2 and 3). For both re-
ceptors, repression mechanism(s) in aorta endothelium and
activation mechanism(s) in brain microvessels endothelium
appear to act at transcriptional level. The role of BBB mi-
cro-environment in the up-regulation of both receptors in en-
dothelial cells of brain microvessels appears crucial, with re-
sults pointing to astrocytes as the main (if not unique)
responsible cellular component. It is reasonable to assume
that the ¢nal expression level of both receptors in endothelial
cells of brain microvessels is de¢ned by the equilibrium be-
tween inhibitory (e.g. cell^cell contact and/or high lipoprotein
levels) and stimulatory (astrocytes induction) signals.
A number of previous experimental results have indeed evi-
denced that several BBB properties are induced by astrocytes.
The induction of the protein(s) responsible for some of these
properties (Q-glutamyltranspeptidase, transferrin receptor,
Fig. 2. Both LDL-R (A) and LOX1-R (B) expression is enhanced
by RA in RBM-EC. Lanes 6 and 11=negative controls; lane
1=xX/HaeIII marker. The panels showed are two (chosen as exam-
ples) of those performed by the scalar number of cycles approach;
the densitometric evaluation of RT-PCR products obtained in the
semiquantitative assays is reported (see Section 2).
Fig. 3. The enhancement of both LDL-R and LOX1-R expression in RBM-EC does not require a physical contact with RA. Lanes 5, 9 and
13=negative controls; lanes 1 and 14=xX/HaeIII marker. The panels showed are two (chosen as examples) of those performed by the scalar
number of cycles approach; the densitometric evaluation of RT-PCR products obtained in the semiquantitative assays are indicated (see Section
2). If the RBM-EC were co-cultivated with RA (astrocytes presence, +) or cultivated alone (astrocytes presence, 3) is indicated, as well as if
the RBM-EC/RA contact was allowed (astrocytes^endothelial cells contact, +) or not allowed (astrocytes^endothelial cells contact, 3).
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P-glycoprotein [16], as well as those leading to tight junctions
formation [9,16]) has been shown to require a physical contact
between astrocytes and endothelial cells ; some other proper-
ties, on the contrary ^ such as the brain-type glucose trans-
porter, [16,26] ; LDL-R [18]; manganese superoxide dismutase
[27]; immunoglobulin-like surface glycoprotein HT7, UEA-1
lectin-binding sites, angiotensin receptors [28] ^ are apparently
elicited by soluble factor(s) produced by astrocytes. In our
experimental system, the induction by RA of LDL-R and of
LOX1-R did not require a close cellular contact of the RA
with the cerebral endothelial cells (Fig. 3). These results
strongly point to soluble factor(s) produced by RA as the
main signal responsible for the modulation of both receptors
expression at the BBB level.
Recent experimental results have evidenced the production
by astrocytes of cytokines and growth factors (tumor necrosis
factor-K, interleukin-1L [27] ; vascular endothelial growth fac-
tor [29] ; basic-¢broblast growth factor [30] ; interleukin-6 [31] ;
monocyte-chemoattractant protein-1 [32,33]). Some of these
macromolecules can presumably act on brain microvessels
endothelial cells to enhance the expression of both LDL-R
and LOX1-R, but further studies are needed to characterize
the speci¢c soluble factor(s) involved in the interaction be-
tween RA and RBM-EC. This interaction is likely to repre-
sent a quite speci¢c signalling pathway since no e¡ect could be
evidenced on the expression of both receptors in a heterolo-
gous co-culture (BAEC/RA) system (Fig. 4). The ¢nding of
this high speci¢city of interaction is in agreement with pre-
vious works on LDL-R [18] and on glucose uptake [26]. It
should however be pointed out that astrocytes have been re-
ported to have the capacity of inducing some BBB properties
also in non-neural endothelial cells [9,16].
The detection, in RA, of a high level of expression of both
LDL-R and LOX1-R (Figs. 1 and 2) stresses a direct role of
these cells also in the maintenance of the lipid composition of
the cellular and extracellular environment of the brain. Astro-
cytes appear therefore as one of the possible recipients for
native and modi¢ed LDL that cross the BBB. LDL-R has
been clearly shown [17] to be directly involved in native
LDL transcytosis across the BBB. Some experimental results
have on the other hand evidenced an uncoupling, in primary
cultures of brain endothelial cells, between the binding site(s)
for acetylated LDL and the intracellular degradative pathway
of these modi¢ed lipoproteins [13], suggesting a transcytosis
pathway also for these modi¢ed LDL. The up-regulation of
LOX1-R in BBB and its expression in RA suggest that also
this receptor might have a functional role in the transcytosis
of moderately oxidized LDL through the BBB.
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